| Good control | Poor control |
All of these over past 4 weeks: Daytime symptoms ≤2 days per week No limitation of activities No symptoms during night or on waking Reliever use ≤2 days per week* | Any of these over past 4 weeks: Daytime symptoms >2 days per week Any limitation of activities Any symptoms during night or on waking Reliever use >2 days per week* |
Additional information
*Do not include short-acting beta2 agonist (salbutamol or terbutaline) taken prophylactically before exercise. Do not include reliever use for patients using an anti-inflammatory reliever (budesonide-formoterol or beclometasone-formoterol) in an AIR-only or MART regimen.